BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28539279)

  • 1. [Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro].
    Li QX; Zhang P; Liu F; Wang XZ; Li L; Wang ZK; Jiang CC; Zheng HL; Liu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):588-593. PubMed ID: 28539279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.
    Liu Z; Sun Y; Hong H; Zhao S; Zou X; Ma R; Jiang C; Wang Z; Li H; Liu H
    Am J Cancer Res; 2015; 5(9):2673-85. PubMed ID: 26609475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors.
    Birsoy K; Wang T; Possemato R; Yilmaz OH; Koch CE; Chen WW; Hutchins AW; Gultekin Y; Peterson TR; Carette JE; Brummelkamp TR; Clish CB; Sabatini DM
    Nat Genet; 2013 Jan; 45(1):104-8. PubMed ID: 23202129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 3-bromopyruvate on mitochondrial membrane potential and apoptosis of human breast carcinoma SK-BR-3 cells].
    Zhang Y; Liu Z; Zhang Q; Chao Z; Zhang P; Xia F; Jiang C; Liu H; Jiang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1304-7. PubMed ID: 24067208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway.
    Liu Z; Zhang YY; Zhang QW; Zhao SR; Wu CZ; Cheng X; Jiang CC; Jiang ZW; Liu H
    Anticancer Drugs; 2014 Apr; 25(4):447-55. PubMed ID: 24492287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
    Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
    Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters.
    Gan L; Xiu R; Ren P; Yue M; Su H; Guo G; Xiao D; Yu J; Jiang H; Liu H; Hu G; Qing G
    Oncogene; 2016 Jun; 35(23):3037-48. PubMed ID: 26434591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
    Kim SH; Singh SV
    Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of downregulation of MCT1 on the proliferation of glioma cells].
    Zhou HG; Zhang JD; Zhang YF
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):208-213. PubMed ID: 30917457
    [No Abstract]   [Full Text] [Related]  

  • 11. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
    Aveseh M; Nikooie R; Aminaie M
    J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma microenvironment via miR-449a/MCT1.
    Sheng Y; Jiang Q; Dong X; Liu J; Liu L; Wang H; Wang L; Li H; Yang X; Dong J
    Biomed Pharmacother; 2020 Jan; 121():109610. PubMed ID: 31710894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
    Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
    Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
    J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
    Wang TA; Zhang XD; Guo XY; Xian SL; Lu YF
    Oncol Rep; 2016 Mar; 35(3):1287-96. PubMed ID: 26708213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
    Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
    Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
    Chen F; Wang H; Lai J; Cai S; Yuan L
    Int J Cardiol; 2018 Sep; 266():236-241. PubMed ID: 29735421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
    Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
    Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.